ASCO GI 2021 | Next-generation sequencing and emerging targets

Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, discusses the use of next-generation sequencing and emerging targets in patients with gastrointestinal (GI) cancer and highlights key actionable mutations present in GI malignancies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).